Abstract
Objective: To determine whether commencement of antibiotics within 3 postnatal days in preterm, very low birth weight (VLBW; ≤1500 g) infants is associated with the development of necrotizing enterocolitis (NEC). Study design: Preplanned statistical analyses were done to study the association between early antibiotic treatment and later NEC development, using the NEOMUNE-NeoNutriNet cohort of VLBW infants from 13 neonatal intensive care units (NICUs) in 5 continents (n = 2831). NEC incidence was compared between infants who received early antibiotics and those who did not, with statistical adjustments for NICU, gestational age, birth weight, sex, delivery mode, antenatal steroid use, Apgar score, and type and initiation of enteral nutrition. Results: The incidence of NEC was 9.0% in the group of infants who did not receive early antibiotics (n = 269), compared with 3.9% in those who did receive early antibiotics (n = 2562). The incidence remained lower in the early antibiotic group after stepwise statistical adjustments for NICU (OR, 0.57; 95% CI, 0.35-0.94, P <.05) and other potential confounders (OR, 0.25; 95% CI, 0.12-0.47; P <.0001). Conclusions: In this large international cohort of preterm VLBW infants, a small proportion of infants did not receive antibiotics just after birth, and these infants had a higher incidence of NEC. It is important to better understand the role of such variables as time, type, and duration of antibiotic treatment on NEC incidence, immune development, gut colonization, and antibiotic resistance in the NICU.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of Pediatrics |
| Vol/bind | 227 |
| Sider (fra-til) | P128-134.E2 |
| ISSN | 0022-3476 |
| DOI | |
| Status | Udgivet - 2020 |
Finansiering
This study is part of the NEOMUNE Project, sponsored by the Innovation Fund Denmark (12-132401, to P.S.). Data from Rush University Children's Hospital were provided with support from the National Institutes of Health (NR010009). H-C.L. was supported by the Taiwan China Medical University Hospital (DMR-107-183). J.M. and S.Y. were supported by Sanming Project of Medicine in Shenzhen (SZSM201612045) and Funding for the Construction of Key Medical Disciplines in Shenzhen (Affiliated Shenzhen Maternity & Child Healthcare Hospital, Southern Medical University). J.v.G. is director of the Dutch Human Milk Bank and a member of the National Health Council. B.C. serves on scientific advisory boards for Nestlé Nutrition Institute and Danone/Nutricia. K.S. is the Director of the Human Milk Bank in Perth Australia and has received support from Medela and Nestlé Nutrition Institute. P.S. has received grant support from ARLA Foods, Medela, Danone/Nutricia, Biofiber-Damino, Mead Johnson Nutrition, and Nestlé Nutrition Institute. F.B. has received travel support for invited lectures from Abbot Nutrition and Nestlé Nutrition Institute and for participation in an expert working group from Danone/Nutricia. N.E. has received speakers' honoraria from Nestlé Nutrition Institute and Danone/Nutricia, and his department has received research support from Prolacta Bioscience and Danone/Nutricia. The other authors declare no conflicts of interest.
Citationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS